Afya Limited (NASDAQ:AFYA – Get Free Report) has earned a consensus recommendation of “Hold” from the seven research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $17.3750.
A number of research analysts recently commented on AFYA shares. Wall Street Zen raised shares of Afya from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 10th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $22.00 price objective (down previously from $24.50) on shares of Afya in a report on Wednesday, January 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a report on Wednesday, October 8th. Sanford C. Bernstein raised Afya to a “market perform” rating in a report on Friday, January 16th. Finally, Zacks Research cut shares of Afya from a “hold” rating to a “strong sell” rating in a report on Friday, January 9th.
Check Out Our Latest Research Report on AFYA
Institutional Inflows and Outflows
Afya Stock Performance
Shares of Afya stock opened at $14.32 on Friday. The firm has a market capitalization of $1.34 billion, a P/E ratio of 10.30, a P/E/G ratio of 0.52 and a beta of 0.53. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.21. Afya has a 52 week low of $13.12 and a 52 week high of $19.90. The firm’s 50 day moving average is $14.75 and its two-hundred day moving average is $14.94.
Afya Company Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
See Also
- Five stocks we like better than Afya
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
